Accueil>>Signaling Pathways>> PROTAC>>Amino-PEG11-amine

Amino-PEG11-amine

Catalog No.GC63930

L'amino-PEG11-amine, un lieur PROTAC À base de PEG (12 unités) utilisé pour combiner deux ligands À base de monodiéthylstilbestrol (DES), fournit une stratégie alternative pour préparer des antagonistes ER plus sélectifs et actifs pour l'hormonothérapie du cancer du sein.

Products are for research use only. Not for human use. We do not sell to patients.

Amino-PEG11-amine Chemical Structure

Cas No.: 479200-82-3

Taille Prix Stock Qté
50 mg
162,00 $US
En stock
100 mg
261,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Amino-PEG11-amine, a PEG-based (12 units) PROTAC linker used to combine two mono diethylstilbestrol (DES)-based ligands, provides an alternative strategy for preparing more selective and active ER antagonists for endocrine therapy of breast cancer[1].

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

[1]. Shan M, et al. Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. ACS Chem Biol. 2013 Apr 19;8(4):707-15.

Avis

Review for Amino-PEG11-amine

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Amino-PEG11-amine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.